Insights

Manufacturers

Webinar: The Caregiver and Patient Support Programme

Innomar Strategies

July 2020

Manufacturers

Webinar: Utilizing Real World Evidence Across the Product Life Cycle

Innomar Strategies

June 2020

Manufacturers

Time-to-treatment initiation (TTI) in community infusion clinics - decreasing wait times for Canadian oncology patients

Innomar Strategies

May 2020

Manufacturers

Regulatory Services: Submission Filing

Anne Tomalin

Quality, Regulatory & Safety

May 2020

Manufacturers

Regulatory Services: Submission and Product Lifecycle Considerations

Anne Tomalin

Quality, Regulatory & Safety

May 2020

Manufacturers

Regulatory Services: How are products approved?

Anne Tomalin

Quality, Regulatory & Safety

May 2020

Manufacturers

Regulatory Services: Navigating Clinical Trial applications

Anne Tomalin

Quality, Regulatory & Safety

May 2020

Manufacturers

Commercializing in Canada: Quality Assurance and GMP Services

Innomar Strategies

April 2020

Manufacturers

Commercializing in Canada: Regulatory Publishing and Submissions

Innomar Strategies

April 2020

Manufacturers

Webinar: Health Canada’s Regulatory and Quality approach to addressing COVID-19 challenges

Innomar Strategies

April 2020

Manufacturers

3PL & Importation: Cost savings through Innomar's scalable supply chain solutions.

Innomar Strategies

March 2020

Manufacturers

3PL & Importation: Quality-assured, temperature-controlled and secure GMP-compliant facility.

Innomar Strategies

March 2020

Manufacturers

3PL & Importation: Supporting your product commercialization through Importation

Innomar Strategies

March 2020

Manufacturers

Why Canada: Leveraging our partnerships and relationships to assist in your launch strategy.

Sandra Anderson

Commercialization and Strategy

March 2020

Manufacturers

Why Canada: How we help Pharmaceutical Manufacturers commercialize their products in Canada.

Sandra Anderson

Commercialization and Strategy

February 2020

Manufacturers

Why Canada: Is Canada an attractive market for global pharmaceutical manufacturers?

Sandra Anderson

Commercialization and Strategy

January 2020

Manufacturers

InnomarLive 2019: Commercializing in Canada

Innomar Strategies

December 2019

Manufacturers

Insight Series: The Value of Real-World Evidence in Canadian Drug Commercialization – Part 1

Innomar Strategies

January 2019

InnomarLive Summary: Healthcare Innovation

Innomar Strategies

December 2018

Manufacturers

Insight Series: Value of Patient Support Programs for Specialty Medications in Canada

Innomar Strategies

May 2018

Infographic: The Route to Market Access in Canada

Innomar Strategies

May 2018

Infographic: The Road to Commercialization in Canada

Innomar Strategies

May 2018

Insight Series: Biosimilars in Canada

Innomar Strategies

January 2018

Drug Reimbursement in Canada

Innomar Strategies

September 2017

Improved Health Outcomes in Patients Receiving Health Case Management

Innomar Strategies

April 2017

Understanding the Journey of a Person with a Rare Disease

Innomar Strategies

February 2017

Specialty pharmacies enhance patient outcomes [Pharmacy Practice Plus]

Jason Zabransky

Specialty Operations

January 2017

Case Study: Patient-centric Care in Rare Disease

Innomar Strategies

July 2016

Future of Patient Support Programs in Canada

Sandra Anderson

Commercialization and Strategy

June 2016

Case Study: Discovering New Opportunities for Growth in a Niche Market

Innomar Strategies

April 2015

Case Study: Leveraging Physician Relationships to Co-create Patient Support

Innomar Strategies

April 2015

Case Study: Optimizing a Patient Support Program to Improve Therapy Adherence

Innomar Strategies

April 2015

Support Programs Designed to Assist Patients and Their Families

Sandra Anderson

Commercialization and Strategy

March 2014

Nurse-led Health Case Management

Innomar Strategies

Big Wins in Record Time for Gaining Market Access with Phase II Data

Innomar Strategies